Rogue R&D claim repayments could cost SMEs millions

16 December 2021

Must read

standard.co.uk

A leading research and development (R&D) tax expert with UK Top 10 firm Azets, the largest regional accountancy firm and business advisor to SMEs, has issued a warning to businesses…

The post Rogue R&D claim repayments could cost SMEs millions appeared first on London Business News | Londonlovesbusiness.com.

» Read More

Tags
Business News
finance
R&D
SMEs
Tax

We got an AI to debate itself, so what did it say?

France bans all British tourists over concerns of the ‘extremely rapid spread of the Omicron variant in the UK’

Germany ranks as the worst G10 nation for real wage growth with UK sitting mid-table

Government needs to take action as 80% of UK drivers won’t buy electric vehicles due to rise in electricity costs

EverCraft Ecotechnologies creates future market with innovative solution from ecoCNTs

Unilever raises full-year sales forecasts after price hike

What is an after dinner speaker and what do they do

Germany ranks as the worst G10 nation for real wage growth with UK sitting mid-table

Government needs to take action as 80% of UK drivers won’t buy electric vehicles due to rise in electricity costs

EverCraft Ecotechnologies creates future market with innovative solution from ecoCNTs

Unilever raises full-year sales forecasts after price hike

What is an after dinner speaker and what do they do

Rogue R&D claim repayments could cost SMEs millions

Must read

Study reveals hidden mental health symptoms in people with autoimmune diseases

Large dusty clumps around young star provide insight into how planets are born

Can You Really Offset Your Carbon Footprint From Flying?

Michael Gove: Labour energy policy would ‘give jobs to Russian workers’

Latest article

Study reveals hidden mental health symptoms in people with autoimmune diseases

Large dusty clumps around young star provide insight into how planets are born

Can You Really Offset Your Carbon Footprint From Flying?

Michael Gove: Labour energy policy would ‘give jobs to Russian workers’

New immunotherapy drug shows promise as cancer treatment, research suggests